Last reviewed · How we verify
NCT06623123
Oto Smartphone App in Treating Tinnitus Amongst Adult Patients Compared with Standard Talking Therapies
Phase 3 trial testing Oto Smartphone Application (Oto Health Ltd) in Tinnitus in 160 participants. Currently enrolling.
20 June 2025
Quick facts
| Lead sponsor | East and North Hertfordshire NHS Trust |
|---|---|
| Phase | Phase 3 |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 160 |
| Start date | 20 June 2024 |
| Primary completion | 20 June 2025 |
| Estimated completion | 20 June 2025 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Oto Smartphone Application (Oto Health Ltd)
- Tinnitus Retraining Therapy (TRT)
Conditions studied
- Tinnitus — all drugs for Tinnitus →
Sponsor
East and North Hertfordshire NHS Trust
Who can join
18 and older, any sex, with Tinnitus. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A study that looks at treating tinnitus and its associated burden, insomnia and quality of life effects with a smartphone app when compared with the talking therapies already offered on the national health service. Three separate questionnaires will be used to collect this data from patients at regular time intervals.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Multimodality Smartphone App Delivered Therapy for Tinnitus – A Protocol for a Randomised Controlled Trial
Habeeb A, Vijendren A. · · 2026 · DOI 10.21203/rs.3.rs-7908701/v1
Verify or expand the search:
- PubMed search for NCT06623123
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Tinnitus
Currently open trials in the same condition.
- NCT07393880 — Bimodal Electrical-Sound Stimulation and Auditory Training for Chronic Tonal Tinnitus · NA · recruiting
- NCT07071480 — Noninvasive Therapy for Tinnitus · NA · recruiting
- NCT07435298 — Navigated Repetitive TMS for Chronic Tinnitus · NA · recruiting
- NCT07158034 — Investigating EEG as a Biomarker for Tinnitus Improvement After Bimodal Stimulation · NA · recruiting
- NCT07017998 — External Therapy for Tinnitus Management · NA · recruiting
Other East and North Hertfordshire NHS Trust trials
Trials by the same sponsor.
- NCT07069998 — AI-guided AF Treatment · NA · not yet recruiting
- NCT06915909 — Robotic Prostatectomy Artificial Intelligence Low Pressure Pain (RALP) Trial · NA · not yet recruiting
- NCT06863090 — In Vivo Dosimetry for Brachytherapy Study · recruiting
- NCT06400927 — Safety of AI-Powered Virtual Assistant in Outpatient Management of Heart Failure · NA · recruiting
- NCT06124612 — An Investigator-initiated Linked Study to OCEANIC-AF · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06623123 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by East and North Hertfordshire NHS Trust
- Last refreshed: 2 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06623123.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing